Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis

Five-year therapy with NETA is safe and well tolerated by women with rectovaginal endometriosis. Due to its low cost and good pharmacological profile, it represents a good candidate for long-term treatment in this setting.